IRVINE, Calif., March 18, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has rescheduled its fourth quarter and full year 2019 earnings conference call to Thursday, March 26, 2020, due to scheduling conflicts.

NASHVILLE, Tenn., March 18, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced fourth quarter and full year 2019 financial results. Net Revenues for the fourth quarter were $13.7 million, and for the full year 2019, Net Revenues tota

AUSTIN, Texas, March 18, 2020 /PRNewswire/ -- Everlywell, the digital health company which offers consumers access to at-home lab tests, announces that an at-home collection kit with teleh

SAN DIEGO, March 18, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on March 12, 2020, the Compensation Committe

TITUSVILLE, N.J., March 18, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ponesimod for the treatment of adult patients with relapsing multiple sclerosis (MS).

SAN CARLOS, Calif., March 18, 2020 /PRNewswire/ -- RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies to improve outcomes for cancer and serious autoimmune disease patients, today announced the appointment of Ramesh Baliga, Ph.D., as the Company's Chief Science Officer.  Dr. Ba

ARLINGTON, Va., March 18, 2020 /PRNewswire/ -- Price gouging is up over the past week as communities across North America react to COVID-19 (coronavirus), according to the Better Business Bureau®.

MENLO PARK, Calif., March 18, 2020 /PRNewswire/ -- Earlens Corporation, a medical technology company that has created the world's first nonsurgical hearing solution that directly vibrates the ea

CORNELIUS, N.C., March 18, 2020 /PRNewswire/ -- Bright Path Laboratories, Inc (the "Company" or "BPL"), a leader in continuous flow reactor technology, was recently accepted into the FDA's Emerging Technology Program paving the way for the Company to bring its unique low-cost and scalable technology to the domestic API manufacturing sector.  The Emerging Tech

NEW YORK, March 18, 2020 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the Company") (NASDAQ: INO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Inovio securities be